Veradigm | MDRX - Fremdkapital

Aktienkurs
4.58
Täglich Wechseln
-0.07 -1.40%
Monatlich
1.78%
Jährlich
7.76%
Q1 Prognose
4.44




Fremdkapital Veränderung Datum
Alcidion AUD 318K 376K 2025-12
Ambu A/S DKK 14M 448M 2025-12
Amplifon EUR 1.11B 304.77M 2025-09
Cardinal Health USD 8.35B 633M 2025-12
Centene USD 17.35B 194M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Cigna USD 30.95B 4.47B 2025-09
Coloplast 21.39B 1.34B 2025-12
Computer Programs Systems USD 161.36M 1.74M 2025-09
Convatec Group USD 1.18B 211.4M 2024-12
CVS Health USD 60.5B 6M 2025-12
Diasorin EUR 472.05M 199.95M 2025-06
Elevance Health USD 30.8B 376M 2025-12
General Electric Aerospace USD 18.81B 37M 2025-12
Gulf Medical Proj AED 3.1M 151K 2025-12
Humana USD 12.37B 238M 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Laboratory Of America USD 5.15B 800K 2025-12
Maximus USD 1.51B 227.61M 2025-12
McKesson USD 5.43B 586M 2025-12
Med Life RON 1.71B 260.03M 2025-12
Molina Healthcare USD 3.95B 98M 2025-12
Omnicell USD 167.6M 302K 2025-12
Oriola-kd EUR 38.3M 600K 2025-12
Owens Minor USD 1.8B 35.38M 2025-12
Quest Diagnostics USD 5.17B 4M 2025-12
Rede D'or Sao Luiz BRL 47.49B 2.56B 2025-12
Siemens Healthineers EUR 9.85B 1.49B 2025-12
Sonova Holding CHF 1.39B 209.8M 2025-06
Supermax Corporation Bhd MYR 17.03M 581K 2025-12
UnitedHealth USD 72.32B 79M 2025-12
Veradigm USD 200.4M 69K 2022-12
Xerox USD 3.48B 785M 2025-06